Diffuse Large B-cell lymphoma |
hsa-miR-21 |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
PTEN |
miR-21 plays an important oncogenic role by down regulating the expression of PTEN and modulating the mTOR pathway in Diffuse Large B-cell lymphoma. |
Go et al., 2015 |
Diffuse Large B-cell lymphoma |
hsa-miR-124 |
OCI-Ly1, OCI-Ly18, SU-DHL-7 |
Up |
PDE4B |
MicroRNA-124 controls glucocorticoid sensitivity by down regulating phosphodiesterase 4B (PDE4B). This is associated with increased cAMP levels, suppression of the mTOR pathway in diffuse large B cell lymphoma. |
Kim et al., 2015 |
Parkinson's disease |
hsa-miR-7 |
HEK293 |
Up |
ALPHA SYNUCLEIN |
MicroRNA-7 protects neurons from cell death by interfering with the MPP+-induced suppression of mTOR signaling pathway. |
Fragkouli et al., 2014 |
Parkinson's disease |
hsa-miR-153 |
HEK293 |
Up |
ALPHA SYNUCLEIN |
MicroRNA-153 protects neurons from cell death by interfering with the MPP+-induced suppression of mTOR signaling pathway. |
Fragkouli et al., 2014 |
Gastric cancer |
hsa-miR-224 |
Gastric cancer tissue |
Up |
MTOR |
MicroRNA-224 down-regulates the expression of mTOR, leads to the activation of cell proliferation in gastric cancer. |
Zhang et al., 2016 |
Gastric cancer |
hsa-miR-18a |
SGC-7901 |
Up |
S6K1 |
Overexpression of miR-18a decreases the phosphorylation of S6K1 and inactivates the mTOR pathway. |
Zheng et al., 2013 |
Gastric cancer |
hsa-miR-18a |
SGC-7901 |
Up |
4E BPl |
Upregulation of miR-18a decreases the phosphorylation of 4E-BPI and inactivates the mTOR pathway. |
Zheng et al., 2013 |
Gastric cancer |
hsa-miR-199a |
Stomach |
Down |
MTOR |
Overexpression of miRNA-199a inhibits cancer cell proliferation through targeting the mTOR signaling pathway. |
Peng et al., 2014 |
Laryngeal squamous cell carcinoma |
hsa-miR-744 |
Lung |
Up |
PTEN |
Down-regulation of miR-744 is associated with suppression of laryngeal squamous cell carcinoma metastasis by inactivating AKT/mTOR signaling pathway. |
Li et al., 2016 |
Chondrosarcoma |
hsa-miR-100 |
CHON-001 |
Down |
MTOR |
MicroRNA-100 functions as a tumor suppressor in chondrosarcoma contributing to anti-chemoresistance through down-regulating the expression of mTOR. |
Zhu et al., 2014 |
Non-small cell lung cancer |
hsa-miR-208a |
Lung |
Up |
P21 |
MicroRNA-208a regulates the proliferation and radiosensitivity of human lung cancer cells by direct inhibition of p21. |
Tang et al., 2016 |
Breast cancer |
hsa-miR-147 |
Breast |
Down |
|
MicroRNA-147 inhibits the proliferation, invasion and migration of breast cancer cells through targeting the Akt/mTOR signaling pathway. |
Zhang et al., 2016 |
Hepatocellular carcinoma |
hsa-miR-132 |
Hep-G2, SMMC-7721, Huh-7 |
Down |
PIK3R3 |
Overexpression hsa-miR-132 inhibits PIK3R3 expression. miR-132 suppresses proliferation, invasion and migration of HCC through inactivating AKT/mTOR pathway |
Liu et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-511 |
Hepatocyte |
Down |
PIK3R3 |
hsa-miR-511 inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma by directly targeting the AKT/mTOR pathway. |
Cao et al., 2015 |
Hepatocellular carcinoma |
hsa-miR-149 |
Hepatocyte |
|
AKT |
hsa-miR-149 acts as a tumor suppressive microRNA and play a vital role in suppressing hepatocellular carcinoma tumorigenesis by modulating by AKT/mTOR pathway. |
Zhang et al., 2014 |
Hepatocellular carcinoma |
hsa-miR-137 |
Hepatocyte |
Down |
AKT |
FoxD3-regulated miR-137 suppresses hepatocellular carcinoma cell growth and metastasis through inhibiting AKT2/mTOR pathway via targeting AKT2. |
Liu et al., 2014 |
Breast cancer |
hsa-miR-99a |
MCF-7, MDA-MB-231 |
Down |
MTOR |
MicroRNA-99a inhibits the breast cancer malignant cancer stem cell phenotype by suppressing the mTOR signaling pathway. |
Yang et al., 2014 |
Cervical cancer |
hsa-miR-634 |
|
Down |
MTOR |
MicroRNA-634 promotes apoptosis and reduces cell proliferation in cervical cancer cells by inhibiting mTOR signaling pathway. |
Cong et al., 2016 |
Cervical cancer |
hsa-miR-99a |
HeLa |
Down |
MTOR |
Increased expression of miR-99a suppresses cell growth and invasion in cervical cancer by inhibiting mTOR signaling pathway. |
Wang et al., 2014 |
Cervical cancer |
hsa-miR-99b |
HeLa |
Down |
MTOR |
Increased expression of miR-99b suppresses cell growth and invasion in cervical cancer by inhibiting mTOR signaling pathway. |
Wang et al., 2014 |
Prostate cancer |
hsa-miR-34a |
LNCaP, DU145, PC-3 |
Down |
ATG4B |
MicroRNA-34a increases chemosensitivity in prostate cancer by inhibiting ATG4B-induced autophagy via AMPK/mTOR pathway. |
Liao et al., 2016 |
Anaplastic thyroid carcinoma |
hsa-miR-99a |
SW1736, ARO, FRO |
Down |
MTOR |
MicroRNA-99a acts as a tumor suppressor and plays an important role in suppressing the tumorigenesis via targeting the mTOR/p- 4E-BP1/p-S6K1 pathway in anaplastic thyroid carcinoma. |
Huang et al., 2015 |